{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:54:43Z","timestamp":1789692883930,"version":"4.0.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T00:00:00Z","timestamp":1631577600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.jcv.2021.104946","type":"journal-article","created":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T00:30:31Z","timestamp":1629419431000},"page":"104946","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Clinical evaluation of the molecular-based BD SARS-CoV-2\/Flu for the BD MAX\u2122 system"],"prefix":"10.1016","volume":"143","author":[{"given":"Sonia","family":"Paradis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Lockamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles K.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcv.2021.104946_bib0001","unstructured":"Johns Hopkins University and Medicine, Coronavirus Resource Center. Mortality analyses. https:\/\/coronavirus.jhu.edu\/data\/mortality. 2020."},{"key":"10.1016\/j.jcv.2021.104946_bib0002","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the chinese center for disease control and prevention","volume":"323","author":"Wu","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jcv.2021.104946_bib0003","unstructured":"Prevention CfDCa. Estimated Influenza Illness, Medical Visits, Hospitalizations, and Deaths in the United States-2019-2020 Influenza Season. https:\/\/www.cdc.gov\/flu\/about\/burden\/2019-2020.html. 2020."},{"key":"10.1016\/j.jcv.2021.104946_bib0004","series-title":"Global Influenza Strategy 2019-2030","year":"2019"},{"key":"10.1016\/j.jcv.2021.104946_bib0005","unstructured":"World Helath Organization. Influenza Update - 383. Accessed December 28, 2020. https:\/\/www.who.int\/influenza\/surveillance_monitoring\/updates\/latest_update_GIP_surveillance\/en\/."},{"key":"10.1016\/j.jcv.2021.104946_bib0006","doi-asserted-by":"crossref","first-page":"726","DOI":"10.7326\/M20-1301","article-title":"Diagnostic testing for severe acute respiratory syndrome\u2013related coronavirus 2","volume":"172","author":"Cheng","year":"2020","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jcv.2021.104946_bib0007","doi-asserted-by":"crossref","DOI":"10.3390\/v8040096","article-title":"Current approaches for diagnosis of influenza virus infections in humans","volume":"8","author":"Vemula","year":"2016","journal-title":"Viruses"},{"key":"10.1016\/j.jcv.2021.104946_bib0008","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1001\/jama.2020.15260","article-title":"What happens when COVID-19 collides with flu season?","volume":"324","author":"Rubin","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jcv.2021.104946_bib0009","article-title":"Clinical and experimental factors that affect the reported performance characteristics of rapid testing for SARS-CoV-2","author":"Parvu","year":"2021","journal-title":"medRxiv"},{"key":"10.1016\/j.jcv.2021.104946_bib0010","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/jmv.24373","article-title":"Factors associated with real-time RT-PCR cycle threshold values among medically attended influenza episodes","volume":"88","author":"Spencer","year":"2016","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.jcv.2021.104946_bib0011","unstructured":"U.S. Food and Drug Administration. BD SARS-CoV-2\/Flu for BD MAX System - Letter of Authorization. 2021."},{"key":"10.1016\/j.jcv.2021.104946_bib0012","unstructured":"U.S. Food and Drug Administration. Coronavirus Disease 2019 (COVID-19) Emergency Use Authorization for Medical Devices\u2013In Vitro Diagnostics EUAs. https:\/\/www.fda.gov\/medical-devices\/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices\/vitro-diagnostics-euas#individual-molecular."},{"key":"10.1016\/j.jcv.2021.104946_bib0013","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1148\/radiol.2015151516","article-title":"STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies","volume":"277","author":"Bossuyt","year":"2015","journal-title":"Radiology"},{"key":"10.1016\/j.jcv.2021.104946_bib0014","unstructured":"U.S. Food and Drug Administration. Guidance for Industry and FDA Staff. Class II special controls guidance document: respiratory viral panel multiplex nucleic acid assay. 2009."},{"key":"10.1016\/j.jcv.2021.104946_bib0015","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.rbmo.2020.06.001","article-title":"Testing for SARS-CoV-2 (COVID-19): a systematic review and clinical guide to molecular and serological in-vitro diagnostic assays","volume":"41","author":"La Marca","year":"2020","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.jcv.2021.104946_bib0016","unstructured":"Centers for Disease Control. Influenza (Flu). Accessed December 16, 2020. https:\/\/www.cdc.gov\/flu\/professionals\/diagnosis\/overview-testing-methods.htm."},{"key":"10.1016\/j.jcv.2021.104946_bib0017","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa1706","article-title":"Antigen-based testing but not real-time polymerase chain reaction correlates with severe acute respiratory syndrome coronavirus 2 viral culture","author":"Pekosz","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jcv.2021.104946_bib0018","series-title":"BD SARS-CoV-2 Reagents for BD MAX\u2122 System","year":"2020"},{"key":"10.1016\/j.jcv.2021.104946_bib0019","series-title":"BD SARS-CoV-2\/Flu For BD MAX\u2122 System","year":"2021"},{"key":"10.1016\/j.jcv.2021.104946_bib0020","series-title":"Biomerieux BioFire\u00ae Respiratory Panel 2.1 (RP2.1)","year":"2020"},{"key":"10.1016\/j.jcv.2021.104946_bib0021","series-title":"BD BioGX SARS-CoV-2 Reagents for BD MAX\u2122 System","year":"2020"},{"key":"10.1016\/j.jcv.2021.104946_bib0022","unstructured":"U.S. Food and Drug Administration. SARS-CoV-2 Reference Panel comparative Data. https:\/\/www.fda.gov\/medical-devices\/coronavirus-covid-19-and-medical-devices\/sars-cov-2-reference-panel-comparative-data. 2020."},{"key":"10.1016\/j.jcv.2021.104946_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2020.198114","article-title":"COVID-19 vaccine: a comprehensive status report","volume":"288","author":"Kaur","year":"2020","journal-title":"Virus Res."},{"key":"10.1016\/j.jcv.2021.104946_bib0024","unstructured":"Centers for Disease Control. Similarites and differences between Flu and COVID-19. Accessed December 28, 2020. https:\/\/www.cdc.gov\/flu\/symptoms\/flu-vs-covid19.htm#:\u223c:text=Flu%20viruses%20can%20cause%20mild,signs%20and%20symptoms%20listed%20above.&text=COVID%2D19%20seems%20to%20cause,loss%20of%20taste%20or%20smell."},{"key":"10.1016\/j.jcv.2021.104946_bib0025","unstructured":"Centers for Disease Control and Prevention. Stay at home when you are sick. Accessed December 28, 2020. https:\/\/www.cdc.gov\/flu\/business\/stay-home-when-sick.htm#:\u223c:text=Individuals%20with%20suspected%20or%20confirmed,3%20days%20of%20their%20illness."},{"key":"10.1016\/j.jcv.2021.104946_bib0026","unstructured":"Centers for Disease Control and Prevention. Options to reduce quarantine for contacts of persons with SARS-CoV-2 infection using symptom monitoring and diagnostic testing. Accessed December 28, 2020. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/more\/scientific-brief-options-to-reduce-quarantine.html."},{"key":"10.1016\/j.jcv.2021.104946_bib0027","unstructured":"U.S. Food and Drug Administration. Tamiflu (oseltamivir phosphate) Information. https:\/\/www.fda.gov\/drugs\/postmarket-drug-safety-information-patients-and-providers\/tamiflu-oseltamivir-phosphate-information. 2018."}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653221002134?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653221002134?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T03:15:01Z","timestamp":1761362101000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653221002134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":27,"alternative-id":["S1386653221002134"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2021.104946","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.02.23.21251915","asserted-by":"object"}]},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical evaluation of the molecular-based BD SARS-CoV-2\/Flu for the BD MAX\u2122 system","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2021.104946","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Becton, Dickinson and Company. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104946"}}